|
|
Article: CIBA VISION: CIBA Vision receives FDA approval for an anti-allergy eye drop.
- Article from:
- M2 Presswire
- Article date:
- July 21, 1999
|
Copyright informationCOPYRIGHT 1999 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-21 July 1999-CIBA VISION: CIBA Vision receives FDA approval for anti-allergy eye drop (C)1994-99 M2 COMMUNICATIONS LTD
RDATE:190799
ATLANTA, GA -- CIBA Vision, the eye care unit of Novartis AG, has received approval from the US Food and Drug Administration (FDA) for marketing ZADITOR (ketotifen fumarate ophthalmic solution, 0.025). ZADITOR is an eye drop for the temporary prevention of itching of the eye due to allergic conjunctivitis. ZADITOR, which contains ketotifen fumarate, is indicated every 8 -- 12 hours.
CIBA Vision submitted the New Drug Application (NDA) for ZADITOR on December 31, 1998. The FDA granted priority review ...
Related newspaper, magazine, and journal articles:
|